Asosiy kontentga oʻtish
AkademIndex

Mahsulotlar

Ishlab chiquvchilar uchun

AkademBaseEkotizim uchun ochiq API
← Ishga qaytish

Ushbu ish iqtibos qilgan ishlar

134 ta ish

Ish: A comprehensive review of immunotherapy in gastrointestinal tumors with a focus on the role of combination therapy with PARP inhibitors

  1. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis

    Catherine de Martel, Damien Georges, Freddie Bray +2

    Maqola20197 iqtibos
    ABI

  2. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries

    Claudia Allemani, Tomohiro Matsuda, V Di Carlo +97

    MaqolaGlobal Cancer Incidence and ScreeningThe Lancet20183 iqtibos
    ABI

  3. PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer

    Andreas D. Hartkopf, Florin‐Andrei Taran, Markus Wallwiener +4

    Sharh maqola20163 iqtibos
    ABI

  4. Inhibitors of immune checkpoints—PD-1, PD-L1, CTLA-4—new opportunities for cancer patients and a new challenge for internists and general practitioners

    Marek Z. Wojtukiewicz, Magdalena M. Rek, Kamil Karpowicz +7

    Sharh maqola20213 iqtibos
    ABI

  5. DNA damage repair: historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy

    Ruixue Huang, Ping‐Kun Zhou

    Sharh maqola20213 iqtibos
    ABI

  6. Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer

    Thierry André, Kai‐Keen Shiu, Tae Won Kim +18

    Maqola20203 iqtibos
    ABI

  7. DNA‐damage repair; the good, the bad, and the ugly

    Razqallah Hakem

    Sharh maqola20082 iqtibos
    ABI

  8. Sarlavhasiz

    Boshqa2 iqtibos
    ABI

  9. Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal.

    Lars Gunnar Kindblom, Helen Remotti, Frank Aldenborg +1

    Maqola19982 iqtibos
    ABI

  10. The Critical Need for CD4 Help in Maintaining Effective Cytotoxic T Lymphocyte Responses

    Spyros A. Kalams, Bruce D. Walker

    Sharh maqola19982 iqtibos
    ABI

  11. Cancer immunotherapy: The past, the present and the future

    Christopher R. Parish

    Sharh maqola20032 iqtibos
    ABI

  12. PARP inhibitors: its role in treatment of cancer

    Alice P. Chen

    Sharh maqola20112 iqtibos
    ABI

  13. The standard diagnosis, treatment, and follow-up of gastrointestinal stromal tumors based on guidelines

    Toshirou Nishida, Jean‐Yves Blay, Seiichi Hirota +2

    Sharh maqola20152 iqtibos
    ABI

  14. Mechanisms of DNA damage, repair, and mutagenesis

    Nimrat Chatterjee, Graham C. Walker

    Sharh maqola20172 iqtibos
    ABI

  15. Maintenance Olaparib for Germline <i>BRCA</i> -Mutated Metastatic Pancreatic Cancer

    Talia Golan, Pascal Hammel, Michele Reni +16

    Maqola20192 iqtibos
    ABI

  16. First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial

    Yelena Y. Janjigian, Kohei Shitara, Markus Moehler +26

    Maqola20212 iqtibos
    ABI

  17. Molecular Mechanisms of Parthanatos and Its Role in Diverse Diseases

    Ping Huang, Guangwei Chen, Weifeng Jin +3

    Sharh maqola20222 iqtibos
    ABI

  18. DNA damage-inducing endogenous and exogenous factors and research progress

    Nian Liu, Jiahui Du, Jing Ge +1

    Sharh maqola20242 iqtibos
    ABI

  19. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  20. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  21. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  22. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  23. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  24. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  25. Sarlavhasiz

    Boshqa1 iqtibos
    ABI